Its sales forecast may have disappointed some investors. The company, which has two business units—CooperVision and ...

(February 21, 2024 ) – CooperSurgical is currently facing 8 lawsuits after the Food and Drug Administration recalled defective fertility medicine. Federal authorities disclosed last week that ...

The Cooper Companies, Inc.COO delivered first-quarter fiscal 2025 adjusted earnings per share (EPS) of 92 cents, which ...

What happens when the techies start working from home, and there’s plenty of office space available cheap right next to ...

SAN RAMON, Calif., March 06, 2025 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, today announced financial results for its fiscal first quarter ended ...

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

The Cooper Companies Inc (COO) reports robust Q1 performance with significant gains in revenue and strategic product expansions, despite facing challenges in China and fertility markets.

Its sales forecast may have disappointed some investors. The company, which has two business units—CooperVision and CooperSurgical—has recorded an almost 18% stock-price drop in the past 12 ...

COO conducts its business via two reportable segments — CooperVision (“CVI”) and CooperSurgical (“CSI”). For the first quarter of fiscal 2025, the CVI segment’s revenues totaled $646.1 ...